Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclaimer
- Outline
- Definitions
- Chronic pain - prevalence
- Chronic pain - burden
- Chronic pain - classification
- Chronic primary vs. secondary pain
- Chronic pain
- Neuropathic pain
- Why treat pain?
- Assessment of pain
- Chronic pain is multidimensional
- Mechanisms contributing to pain chronification
- Primary afferent input & spontaneous pain
- Psycho-social components & pain chronification
- Current approaches for managing chronic pain
- Chronic low back pain: pharmacologic therapies
- Safety issues & medications for chronic pain
- Approaches for managing chronic pain: opioids
- Medicinal cannabis and cannabinoids & pain
- Non-pharmacological treatment for chronic pain
- Pharmacotherapy for neuropathic pain (1)
- Pharmacotherapy for neuropathic pain (2)
- NNT over the years in neuropathic pain studies
- Combination pharmacotherapy
- Key limitations of pharmacotherapy
- Newly approved drugs for neuropathic pain
- Recent developments in pharmacotherapy
- Heterogeneity in neuropathic pain presentation
- Sensory profiling: mechanism-based approach
- Oxcarbazepine effect depends on pain type
- Pain modulation & duloxetine efficacy
- Future directions (1)
- Future directions (2)
- Future directions - neuro-immune crosstalk
- Summary
- Thank you!
Topics Covered
- Prevalence and burden of chronic pain
- Different approaches for pain classification
- Assessment: pain severity vs. function
- Factors contributing to pain chronification and possible targets for interventions
- Current approaches for chronic pain management
- Analgesics – efficacy vs. safety
- Latest developments in pharmacotherapy for neuropathic pain
- Future directions for treatment
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Haroutounian, S. (2019, March 31). Developments & future directions in the management of chronic pain [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 20, 2024, from https://doi.org/10.69645/SSFV9040.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Simon Haroutounian has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Periodic Reports: Advances in Clinical Interventions and Research Platforms
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Simon Haroutounian.
I'm an assistant professor of anesthesiology at Washington University School of Medicine.
I work as a clinical pharmacist in the
Multidisciplinary Pain Management Team at Washington University Pain Center.
In my talk today, we'll overview different approaches,
primarily pharmacological ones, for the management of chronic pain.
I will discuss developments and future directions.
0:30
In this talk, I will provide
some background on the prevalence and burden of chronic pain,
as well as, we'll look at different ways to classify chronic pain.
We will, then, discuss different biological and psychological factors that can contribute
to the chronification of pain or the transition from acute to chronic pain, if you will.
We'll discuss possible targets for interventions to avoid this pain chronification.
I will provide an overview of some of
the current approaches for managing chronic pain and
focus primarily on recent evidence on the efficacy of pharmacological therapies,
highlighting some interesting future directions.
1:08
So, let's start with some definitions.
ISP, or the International Association for the Study of Pain,
defines pain is an unpleasant sensory and
emotional experience associated with actual or potential tissue damage.
I would like to highlight the two sensory and emotional components.
Because while in acute pain,
the experience may be mostly sensory or biological,
in chronic pain the emotional experience tends to play
quite a dramatic role in how patients perceive their pain.
Pain is typically divided into acute and chronic.
While most of us can intuitively say what chronic pain is,
the definition of chronic pain has not been that straightforward.
So, it used to move between defined time cutoffs for pain duration,
to the idea that chronic pain is pain that
persists past normal healing time of a tissue that has been damaged.
The recent 2019 definition
comes back to duration and defines chronic pain
as pain that has been going on for more than three months.
This temporal definition is mainly due to the fact that we can't always
identify the tissue damage or the inciting event that triggered that chronic pain.